LYMPHOCYTE TYPING, POSITIVE CONTROL— 510(k) K761009

Name: FDA 510(k) clearance K761009
Creator: U.S. Food and Drug Administration
Published: 1977-04-06

Substantially Equivalent

Hyland Therapeutic Div., Travenol Laboratories

FDA 510(k) clearance K761009 for LYMPHOCYTE TYPING, POSITIVE CONTROL, Substantially Equivalent on 1977-04-06. Applicant: Hyland Therapeutic Div., Travenol Laboratories. Device class: 1.

Clearance details

Applicant: Hyland Therapeutic Div., Travenol Laboratories
Product code: Code LGO
Device class: Class 1
Regulation: 21 CFR 864.7675
Advisory panel: Hematology
Date received: 1976-11-02
Decision date: 1977-04-06
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Mchenry, IL, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code LGO

view all

K894947 — PLATELIA TOXO IGG KIT1990-03-23
K874544 — SNAP(R) CAMPYLOBACTER CULTURE IDENT DIAGNOSTIC KIT1988-08-12
K791118 — HLA CONTROL SERA1979-08-03
K761008 — LYMPHOCYTE TYPING, NEGATIVE CONTROL1977-04-06

More clearances from Hyland Therapeutic Div., Travenol Laboratories

view all

K820835 — ALUMINA SILICA-ACTIVATED PARTIAL THROM1982-04-26
K820192 — HAEMOPHILUS INFLUENZAE TYPE B ANTISERUM1982-03-11
K812220 — NEPHELOMETRIC SOLID TURBIDITY STANDARD1981-08-18
K810078 — Q-PAK THERAPEUTIC DRUG MONIT. CONTROL S1981-02-02
K810077 — OMEGA THERAPEUTIC DRUG MONIT. CONTROL S.1981-01-28

Data sourced from openFDA. This site is unofficial and independent of the FDA.